DELCATH SYSTEMS INC

NASDAQ: DCTH (Delcath Systems, Inc.)

Last update: 5 days ago, 3:31PM

7.07

1.67 (30.93%)

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Bullish Bearish
Medical Devices (Global) Bullish Bearish
Stock Delcath Systems, Inc. Bullish Bullish

Analyst Consensus

Strong Sell
Sell
Neutral
Buy
Strong Buy

2 Buy

Avg. Price @ Call: 7.13

Similar Stocks

Stock Market Cap DY P/E P/B
DCTH 196 M - - 13.17
QDEL 3 B - - 0.890
IART 2 B - 52.19 1.35
AHCO 1 B - - 0.900
OFIX 549 M - - 1.01
INGN 208 M - - 1.10

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

Sector Healthcare
Industry Medical Devices
Investment Style Small Value

Ownership

Name Date Shares Held
Hunting Hill Global Capital, Llc 31 Dec 2023 164,846
52 Weeks Range
2.25 - 7.99
Price Target Range
22.00 - 25.00
High 25.00 (Stephens & Co., 253.61%) Buy
Median 23.50 (232.39%)
Low 22.00 (HC Wainwright & Co., 211.17%) Buy
Average 23.50 (232.39%)
Total 2 Buy
Firm Date Target Price Call Price @ Call
HC Wainwright & Co. 15 May 2024 22.00 (211.17%) Buy 7.19
27 Mar 2024 20.00 (182.89%) Buy 5.09
Stephens & Co. 14 May 2024 25.00 (253.61%) Buy 7.07

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No data